Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corporate bonds to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., according to people with knowledge of the matter.
Markets today: Stock bulls reload AI wagers as Nvidia surges 12% bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) — Stocks powered ahead as Nvidia Corp.’s bullish outlook rekindled the artificial-intelligence mania and data showed the world’s largest economy is still going strong. The most-valuable chipmaker soared 15%, putting it on course to add more than $230 billion to its market capitalization. That would be the biggest single-session increase in value ever …
(Bloomberg) — The stock rally powered ahead as Nvidia Corp.’s bullish outlook rekindled the artificial-intelligence mania and data showed the world’s largest economy is still going strong. From the US to Europe and Japan, equities hit all-time highs, with the most-valuable chipmaker up 15% Thursday and on course to add more than $230 billion to…
AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.